Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for PDL1 (gene)
Most Correlated Studies
- Breast adenocarcinoma MDA-MB-231 cells with shRNA knowdown of PDL1
- Renal cell carcinoma PDL1+ biopsies of nivolumab non-responders and partial and complete responders
- Orthotopic tumor primary and metastatic kidney cancer RENCA cells resistant to anti-PDL1 treatment
- Lung squamous cell carcinoma epithelial and stromal cells from LKB1 and PTEN double KO
Most Relevant Literature
- Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy.
- CD274 (PD-L1) negatively regulates M1 macrophage polarization in ALI/ARDS.
- Oral PD-L1 Inhibitors Crowd into the Clinic.
- The current status and future of PD-L1 in liver cancer.
- Discovery of Novel PD-L1 Small-Molecular Inhibitors with Potent In Vivo Anti-tumor Immune Activity.
Most Relevant Clinical Trials
- Texture Features and PDL1 in CT-PET 18 FDG
- PDL1 Expression in Cancer (PECan Study).
- A Biomarker Exploratory Study of Dual Blockade of PD1/PDL1 and CTLA4 and Anti-angiogenic Therapy
- Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients …
- PDL1 in Ovarian High Grade Serous Carcinoma
